The Role of External Quality Assessments(PT) in HIV Quality Assurance��
UMLTA CPD Webinar Session 22
29th August 2024
Silence Zuriat
Uganda Virus Research Institute
Presentation outline
Overview of EQA (Definition, EQA approaches, Benefits of EQA, characteristics & general cycle of EQA
EQA policy requirements, stakeholder roles
3
3
1
Challenges and Recommendations
2
Review performance in EQA schemes in the past year (HIV, UBTS & CD4 )
(ref; WHO LQMS manual)
Definition of External Quality Assessment (EQA)
EQA Comparisons are;
( ref: ISO 15189:2022,clause 7.3.7.3 (e)
Definition of EQA (2)
( ref: ISO 15189:2022,clause 7.3.7.3 (f)
Approaches to EQA
Approaches
Proficiency Testing
Rechecking Re-testing
On-site Evaluation
Others include:
Interlaboratory comparison programme(s)
Benefits of EQA to participating labs/POCTs
Principle characteristics of EQA
EQA general cycle
EQA sample received
Lab analyses EQA sample
Results sent to EQA provider
EQA Provider sends report
EQA report received
EQA report reviewed
CA taken if any
1
2
3
4
5
6
7
EQA Policy requirements
1. National HTS Policy
2. Guidelines for the NEQAP
3. National Certification Framework.
HIV EQA/PT Program Stakeholders
- large volume facilities across the country
Scale up of PT Program
Coverage of the HIV PT Program
Facilities
(n = 3759)
Testing points
(n = 13,189)
Testers
(n = 28,342 )
Participation in PT Program
HIV EQA Response by Cadre
HIV EQA Pass rate by Cadre
HIV EQA Pass rate (Apr-Jun 24)
HIV EQA Ungraded results (Apr-Jun 24)
CD4 EQA Performance
UBTS EQA Performance
Blood bank | Region | Quarter | | | |||||||
| | Apr-Jun '23 | Jul-Sept '23 | Oct-Dec '23 | Jan-Mar '24 | Apr-Jun 24 | | ||||
| | Responded(Yes/No) | Passed (Yes/No) | Responded(Yes/No) | Passed (Yes/No) | Responded(Yes/No) | Passed (Yes/No) | Responded(Yes/No) | Passed (Yes/No) | Responded | Passed |
| West Nile | No | NA | Yes | No(Failed Hep C serology) | Yes | Yes | Yes | Yes | Yes | Yes |
| Mid west | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Mid north | Yes(Only submitted 2 parameters) | Yes | Yes | Yes | Yes | Yes | NS | NA | Yes | Yes |
| Mid north | Yes(Only submitted 2 parameters) | Yes | Yes | Yes | Yes | Yes | Yes | No(Failed Rh factor typing) | Yes | Yes |
| Mid East | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| South West | Yes | Yes | Yes | Yes | Yes | No(Failed Rh factor typing) | Yes | Yes | Yes | Yes |
| Kampala | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Kampala | Yes | Yes | Yes | Yes | Yes | No(Failed ABO blood grouping) | Yes | No(Failed Syphilis) | Yes | Yes |
6 parameters are assessed including; HIV, syphilis, Hepatitis B and Hepatitis C serology; Rh factor typing; and ABO blood grouping | | | |||||||||
Challenges
Key Points
Contacts
UVRI Toll free:
Call: 0800100410
WhatsApp:+256784269925
SMS: 8227